Delivery Order SPE2DB22D2214-SPE2DB25FS6AG
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Azithromycin 250 mg tablets in quantities of 30 units. This contract, valued at $6,100.26, represents a firm fixed price delivery order with an ultimate completion date of August 1, 2025. The award is non-competitive and carries no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform...
- The Defense Logistics Agency awarded a $1,526.00 delivery order to AmerisourceBergen Drug Corp for Azithromycin 250 mg tablets (30-count units) on July 25, 2025, with an ultimate completion date of July 28, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Azithromycin 500 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $1,979.82 and an ultimate completion date of August 6, 2025. The contract was competitively awarded with no set-aside designation, and performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Azithromycin 500 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $4,486.90 and a completion date of August 1, 2025. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Azithromycin 500 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with a ceiling value of $16,453.75 and an ultimate completion date of July 25, 2025. The contract was competitively awarded with no set-aside designation, and the place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $6,858.00 to AmerisourceBergen Drug Corp for the supply of Azithromycin 250 mg tablets (30-count packages) on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order is non-set-aside and represents a competitive award to the vendor. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is...
- The Defense Logistics Agency awarded a $3,057 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Azithromycin 500 mg tablets in quantities of 30 units. This contract, issued on July 31, 2025, with an ultimate completion date of August 1, 2025, represents a competitively awarded, non-set-aside delivery order supporting federal medical procurement requirements. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $1,076.88 to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Azithromycin 250 mg tablets (packaged as 6-unit strips). This is a firm fixed-price delivery order with an ultimate completion date of July 21, 2025, and represents a non-set-aside competitive award. The pharmaceutical product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Azithromycin 250 mg tablets in unit of issue packages of 6s, with a ceiling value of $2,244.76. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract is scheduled for...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency on July 29, 2025, for the supply of Azithromycin 500 mg tablets in packages of 30 units. This is a firm fixed-price delivery order with a ceiling value of $7,620.00 and an ultimate completion date of July 30, 2025. The contract utilizes no set-aside designation and is competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate...
- SPE2DB22D2214Indefinite Delivery Contract
- SPE2DB22D2214-SPE2DB25FS6AGDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Azithromycin 250 mg tablets in quantities of 30 units, with a ceiling value of $6,311.42. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award based on capability. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. This prime vendor contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly within military and veteran healthcare systems. The company maintains an extensive portfolio of delivery orders with the DLA across multiple therapeutic domains, including antibiotics, specialty medications, and generic drugs. The delivery order is scheduled for ultimate completion on August 5, 2025, with performance occurring at the contractor's Conshohocken facility. This award exemplifies AmerisourceBergen's role in the Defense Health Agency's pharmaceutical supply chain, ensuring availability of essential medications to support military operational readiness and healthcare delivery.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.3k | 8/4/25 |